Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 9
2004 6
2005 8
2006 10
2007 9
2008 7
2009 6
2010 13
2011 10
2012 19
2013 16
2014 21
2015 15
2016 21
2017 17
2018 22
2019 25
2020 22
2021 33
2022 21
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea.
Mok J, Lee M, Kim DK, Kim JS, Jhun BW, Jo KW, Jeon D, Lee T, Lee JY, Park JS, Lee SH, Kang YA, Lee JK, Kwak N, Ahn JH, Shim TS, Kim SY, Kim S, Kim K, Seok KH, Yoon S, Kim YR, Kim J, Yim D, Hahn S, Cho SN, Yim JJ; MDR-END investigators. Mok J, et al. Among authors: lee t. Lancet. 2022 Oct 29;400(10362):1522-1530. doi: 10.1016/S0140-6736(22)01883-9. Lancet. 2022. PMID: 36522208 Clinical Trial.
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study.
Shim JS, Kim H, Kwon JW, Park SY, Kim S, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Kim SH, Park SY, Cho YJ, Park CS, Jung JW, Park HK, Kim JH, Choi JH, Moon JY, Adcock I, Chung KF, Kim MH, Kim TB; Precision Intervention in Severe Asthma (PRISM) study investigatorsa. Shim JS, et al. Among authors: lee t. World Allergy Organ J. 2023 Dec 12;16(12):100848. doi: 10.1016/j.waojou.2023.100848. eCollection 2023 Dec. World Allergy Organ J. 2023. PMID: 38093952 Free PMC article.
WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Bhavsar P, Adcock I, Chung KF, Kim TB. Pham DD, et al. Among authors: lee t. Ann Allergy Asthma Immunol. 2023 Jun 1:S1081-1206(23)00402-7. doi: 10.1016/j.anai.2023.05.029. Online ahead of print. Ann Allergy Asthma Immunol. 2023. PMID: 37268246
Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study.
Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Adcock I, Bhavsar P, Chung KF, Kim TB. Pham DD, et al. Among authors: lee t. Ann Allergy Asthma Immunol. 2024 Apr;132(4):457-462.e2. doi: 10.1016/j.anai.2023.11.005. Epub 2023 Nov 17. Ann Allergy Asthma Immunol. 2024. PMID: 37977324
301 results